The prognostic role and the tumor characteristics associated with TROP2 expression in CC are unclear, however, recent immunohistochemistry (IHC) studies have indicated high TROP2 levels [[10], [11], [12], [13]]. This evidence concerns the gene TACSTD2 and neoplasm.